欧州の無針注射システムの2028年までの市場予測-地域分析- 製品、技術、タイプ、使用感、投与部位、アプリケーション、エンドユーザー別

欧州のニードルフリー注射システム市場は、2022年の4,378万米ドルから2028年には1億1,476万米ドルに成長すると予測され、2022年から2028年にかけて17.4%のCAGRで成長すると推定されています。

ワクチンとバイオシミラーの需要増が欧州のニードルフリー注射システム市場を後押し

がん、肝炎、糖尿病、その他の急性・慢性疾患など、さまざまな疾患の治療において、バイオシミラーの使用が増加しています。これらの疾患の有病率の上昇に伴い、バイオシミラーのニーズも高まっており、医薬品・医療機器メーカーがバイオシミラーの革新的な送達ソリューションを開発する大きなチャンスとなっています。いくつかのバイオシミラーやワクチンは注射によって投与されるため、針を使わない注射技術の使用は、従来の注射器具や熟練したスタッフがいなくても、バイオシミラーを投与するための使いやすく安全な方法を提供することができます。さらに、多くのバイオ医薬品メーカー、ワクチン会社、無針注射器メーカーは、ワクチン市場の成長性を活用するために、戦略的な買収や提携に乗り出しています。したがって、無針注射技術を用いた効果的で安全なドラッグデリバリー機器の発売は、今後数年間の市場成長を後押しする可能性があります。例えば、2019年1月、Enesi PharmaとGeovaxは、Implavax無針注射装置を使用して投与される複数のワクチンについて協業しました。また、2021年8月には、PharmaJetがZydus Cadilaと、針なし注射による世界初のプラスミドDNA COVID-19ワクチン投与で提携しました。さらに、無針注射技術を用いたCOVID-19 mRNAワクチンの製造・供給についてもAbnovaと提携しています。多くの患者が注射針に対して恐怖心を抱いており、それが注射器の需要の低さにつながっています。そのため、多くの企業が効果的で痛みのないソリューションを備えた無針注射器の開発を目指しているのが現状です。このように、これらの注射器の使いやすさの利点を後押しするこれらすべての要因は、企業が革新的な製品を開発する機会を増やすことになり、予測期間中の欧州無針注射システム市場の成長を後押しすると予想されます。

欧州の無針注射システム市場の概要

欧州の無針注射システム市場は、英国、ドイツ、フランス、イタリア、スペイン、その他欧州に区分されます。フランスやドイツなどの国々は、この地域における針刺し損傷や糖尿病により、無針注射システム市場に最も大きく貢献すると予想されます。国際糖尿病連合（IDF）は、欧州における糖尿病有病率（9.2%）と糖尿病患者数（6100万人）が2045年までに13%増加すると推定しています。シャープス傷害、特に針刺し傷害は、生命を脅かす可能性のある感染症のリスクを増大させます。欧州では毎年、約120万本の針刺し損傷がヘルスケアスタッフによって引き起こされています。汚染された注射針によって感染する危険な血液媒介病原体は、B型肝炎、C型肝炎、HIVなど30種類以上にのぼります。

さらに、ドイツは、無針注射器市場の収益創出と将来の機会という点で、欧州地域の主要な経済圏の一つです。糖尿病などの疾患の場合、薬剤の自己投与に対するニーズが高まっていることが、ドイツにおける無針注射器産業の規模を高めています。さらに、ドイツ全土で喘息などの有病率が高まるにつれ、吸入器の需要も増加すると予想され、それが無針注射システム市場の成長を牽引しています。

欧州の無針注射器システム市場の収益と2028年までの予測（US$Million）

欧州の無針注射システム市場のセグメンテーション

欧州の無針注射システム市場は、製品、技術、タイプ、耐久性、国別に区分されます。製品に基づき、欧州の無針注射システム市場は、充填式無針注射器とプレフィルド無針注射器に二分されます。2022年の市場では、充填式無針注射器セグメントがより大きなシェアを占めています。

技術に基づき、欧州のニードルフリー注射システム市場は、ジェットベースのニードルフリー注射器、スプリングベースのニードルフリー注射器、マイクロアレイパッチ注射器、その他に区分されます。ジェットベースのニードルフリー注射器セグメントは、2022年に市場で最大のシェアを登録しました。

タイプに基づいて、欧州の無針注射システム市場は、液体ベースの無針注射器、発射体ベースの無針注射器、および粉末ベースの無針注射器に分割されます。液体ベースの無針注射器セグメントは、2022年に市場で最大のシェアを登録しました。

耐久性に基づいて、欧州の無針注射器市場は、使い捨てと再利用可能なものに二分されます。再利用可能なセグメントは、2022年に市場でより大きなシェアを占めています。

送達部位に基づき、欧州の無針注射システム市場は、皮下注射器、筋肉内注射器、皮内注射器に区分されます。2022年の市場では、皮下注射器セグメントが最大のシェアを占めています。

用途に基づき、欧州の無針注射器市場は、ワクチンデリバリー、インスリンデリバリー、腫瘍学、疼痛管理、皮膚科学、その他に区分されます。2022年の市場では、ワクチンデリバリー分野が最大のシェアを占めています。

エンドユーザー別に見ると、欧州のニードルフリー注射システム市場は、病院、在宅ケア環境、研究室、製薬・バイオテクノロジー企業、その他に区分されます。2022年の市場では、病院セグメントが最大のシェアを占めています。

国別に見ると、欧州のニードルフリー注射システム市場は、ドイツ、フランス、イタリア、スペイン、英国、その他欧州に区分されます。2022年はドイツが市場を独占しました。

Aijex Pharma International Inc.、Crossject、Ferring B.V.、Medical International Technologies（MIT Canada）Inc.、NuGen Medical Devices、およびZealand Pharma A/Sは、欧州の無針注射システム市場で活動している主要企業です。

目次

第1章 イントロダクション

• 調査範囲
• 洞察パートナーズの調査報告書ガイダンス
• 市場セグメンテーション
  • 欧州のニードルフリー注射システム市場：製品別
  • 欧州のニードルフリー注射システムの市場：技術別
  • 欧州のニードルフリー注射システムの市場：タイプ別
  • 欧州のニードルフリー注射器市場：使用感別
  • 欧州のニードルフリー注射器市場：投与部位別
  • 欧州のニードルフリー注射システム市場：用途別
  • 欧州のニードルフリー注射器市場：エンドユーザー別
  • 欧州のニードルフリー注射システム市場：国別

第2章 欧州のニードルフリー注射システム市場-主要なポイント

第3章 調査手法

• 調査範囲
• 2次調査（セカンダリーリサーチ
• 1次調査

第4章 欧州のニードルフリー注射器市場-市場情勢

• 欧州PEST分析
• エキスパートオピニオン

第5章 欧州のニードルフリー注射器市場-主要市場力学

• 市場促進要因
  • 針刺し損傷別伝染病の発生率の増加
  • 自己注射デバイスを使用する利点
• 市場抑制要因
  • 従来の注射器と比べたニードルフリー注射器の開発コストの高さ
• 市場機会
  • ワクチンやバイオシミラーの需要増加
• 今後の動向
  • ニードルフリー注射器に関する新技術の急増
• 影響度分析

第6章 ニードルフリー注射システム市場-欧州分析

• 欧州ニードルフリー注射システムマーカー収益と予測分析

第7章 ニードルフリー注射システム市場の分析と2028年までの予測-製品別

• 欧州のニードルフリー注射システム市場、製品別2022年・2028年（%）
• 充填式ニードルフリー注射器
• プレフィルドニードルフリーインジェクター（Prefilled Needle Free Injectors

第8章 ニードルフリー注射器市場の分析と2028年までの予測：技術別

• 欧州ニードルフリー注射システム市場：技術別2022年・2028年（%）
• ジェットベース・ニードルフリーインジェクター
• スプリング式ニードルフリーインジェクター
• マイクロアレイパッチインジェクター
• その他

第9章 ニードルフリー注射器市場の分析と2028年までの予測（タイプ別

• 欧州のニードルフリー注射システム市場、タイプ別2022年・2028年（%）
• 液体ベースのニードルフリー注射器
• 投射型ニードルフリー注射器
• パウダーベースのニードルフリー注射器

第10章 欧州ニードルフリー注射器市場の分析と2028年までの予測（ユーザビリティ別

• 欧州のニードルフリー注射システム市場、2022年・2028年使用感別（%）
• ディスポーザブル
• 再使用可能

第11章 欧州のニードルフリー注射システム市場の分析と2028年までの予測：投与部位別

• 欧州のニードルフリー注射システム市場、2022年および2028年の投与部位別（%）
• 皮下注射器
• 筋肉内注射器
• 皮内注射器

第12章 欧州ニードルフリー注射システム市場の分析と2028年までの予測（用途別

• 欧州ニードルフリー注射システム市場：アプリケーション別2022年・2028年（%）
• ワクチンデリバリー
• インスリンデリバリー
• 疼痛管理
• オンコロジー
• 皮膚科学
• その他

第13章 欧州ニードルフリー注射システム市場の分析-エンドユーザー別

• 欧州のニードルフリー注射システム市場：エンドユーザー別2022年・2028年（%）
• 製薬会社、バイオテクノロジー企業
• 病院
• 研究機関
• 在宅医療施設
• その他のエンドユーザー

第14章 欧州のニードルフリー注射システム市場の収益と2028年までの予測- 国別分析

• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • その他欧州

第15章 無針注射器市場-業界情勢

• 市場参入企業の成長戦略（%）
• 有機的な展開
• インオーガニックの開発

第16章 企業プロファイル

• Crossject
• Zealand Pharma A/S
• Medical International Technologies（MIT Canada）Inc.
• NuGen Medical Devices
• Ferring B.V.
• Aijex Pharma International Inc.

第17章 付録

• The Insight Partners について
• 用語集

List Of Tables

• Table 1. Germany: Needle Free Injection System Market, by Product - Revenue and Forecast to 2028 (US$ Thousand)
• Table 2. Germany: Needle Free Injection System Market, by Technology - Revenue and Forecast to 2028 (US$ Thousand)
• Table 3. Germany: Needle Free Injection System Market, by Type - Revenue and Forecast to 2028 (US$ Thousand)
• Table 4. Germany: Needle Free Injection System Market, by Usability - Revenue and Forecast to 2028 (US$ Thousand)
• Table 5. Germany: Needle Free Injection System Market, by Site of Delivery- Revenue and Forecast to 2028 (US$ Thousand)
• Table 6. Germany: Needle Free Injection System Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
• Table 7. Germany: Needle Free Injection System Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
• Table 8. France: Needle Free Injection System Market, by Product - Revenue and Forecast to 2028 (US$ Thousand)
• Table 9. France: Needle Free Injection System Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
• Table 10. France: Needle Free Injection System Market, by Type - Revenue and Forecast to 2028 (US$ Thousand)
• Table 11. France: Needle Free Injection System Market, by Usability - Revenue and Forecast to 2028 (US$ Thousand)
• Table 12. France: Needle Free Injection System Market, by Site of Delivery- Revenue and Forecast to 2028 (US$ Thousand)
• Table 13. France: Needle Free Injection System Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
• Table 14. France: Needle Free Injection System Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
• Table 15. UK: Needle Free Injection System Market, by Product - Revenue and Forecast to 2028 (US$ Thousand)
• Table 16. UK: Needle Free Injection System Market, by Technology - Revenue and Forecast to 2028 (US$ Thousand)
• Table 17. UK: Needle Free Injection System Market, by Type - Revenue and Forecast to 2028 (US$ Thousand)
• Table 18. UK: Needle Free Injection System Market, by Usability - Revenue and Forecast to 2028 (US$ Thousand)
• Table 19. UK: Needle Free Injection System Market, by Site of Delivery- Revenue and Forecast to 2028 (US$ Thousand)
• Table 20. UK: Needle Free Injection System Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
• Table 21. UK: Needle Free Injection System Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
• Table 22. Italy: Needle Free Injection System Market, by Product - Revenue and Forecast to 2028 (US$ Thousand)
• Table 23. Italy: Needle Free Injection System Market, by Technology - Revenue and Forecast to 2028 (US$ Thousand)
• Table 24. Italy: Needle Free Injection System Market, by Type - Revenue and Forecast to 2028 (US$ Thousand)
• Table 25. Italy: Needle Free Injection System Market, by Usability - Revenue and Forecast to 2028 (US$ Thousand)
• Table 26. Italy: Needle Free Injection System Market, by Site of Delivery- Revenue and Forecast to 2028 (US$ Thousand)
• Table 27. Italy: Needle Free Injection System Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
• Table 28. Italy: Needle Free Injection System Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
• Table 29. Spain Needle Free Injection System Market, by Product - Revenue and Forecast to 2028 (US$ Thousand)
• Table 30. Spain: Needle Free Injection System Market, by Technology - Revenue and Forecast to 2028 (US$ Thousand)
• Table 31. Spain: Needle Free Injection System Market, by Type - Revenue and Forecast to 2028 (US$ Thousand)
• Table 32. Spain: Needle Free Injection System Market, by Usability - Revenue and Forecast to 2028 (US$ Thousand)
• Table 33. Spain: Needle Free Injection System Market, by Site of Delivery- Revenue and Forecast to 2028 (US$ Thousand)
• Table 34. Spain Needle Free Injection System Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
• Table 35. Spain Needle Free Injection System Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
• Table 36. Rest of Europe Needle Free Injection System Market, by Product - Revenue and Forecast to 2028 (US$ Thousand)
• Table 37. Rest of Europe: Needle Free Injection System Market, by Technology - Revenue and Forecast to 2028 (US$ Thousand)
• Table 38. Rest of Europe: Needle Free Injection System Market, by Type - Revenue and Forecast to 2028 (US$ Thousand)
• Table 39. Rest of Europe: Needle Free Injection System Market, by Usability - Revenue and Forecast to 2028 (US$ Thousand)
• Table 40. Rest of Europe: Needle Free Injection System Market, by Site of Delivery- Revenue and Forecast to 2028 (US$ Thousand)
• Table 41. Rest of Europe Needle Free Injection System Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
• Table 42. Rest of Europe Needle Free Injection System Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
• Table 43. Organic Developments Done by Companies
• Table 44. Inorganic Developments Done by Companies
• Table 45. Glossary of Terms

List Of Figures

• Figure 1. Europe Needle Free Injection Systems Market Segmentation
• Figure 2. Europe Needle Free Injection Systems Market, By Country
• Figure 3. Europe Needle Free Injection Systems Market Overview
• Figure 4. Fillable Needle-Free Injectors Segment Held Largest Share of Product Segment in Europe Needle Free Injection Systems Market
• Figure 5. UK is Expected to Show Remarkable Growth During the Forecast Period
• Figure 6. Europe: PEST Analysis
• Figure 7. Europe Needle Free Injection Systems Market Impact Analysis of Driver and Restraints
• Figure 8. Europe Needle Free Injection System Market - Revenue Forecast and Analysis - 2020- 2028
• Figure 9. Europe Needle Free Injection Systems Market, by Product 2022 & 2028 (%)
• Figure 10. Fillable Needle Free Injectors: Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 11. Prefilled Needle Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 12. Europe Needle Free Injection Systems Market, by Technology 2022 & 2028 (%)
• Figure 13. Jet-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 14. Spring-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 15. Microarray Patch Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 16. Others - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 17. Europe Needle Free Injection Systems Market, by Type 2022 & 2028 (%)
• Figure 18. Liquid-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 19. Projectile-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 20. Powder-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 21. Europe Needle Free Injection Systems Market, by Usability 2022 & 2028 (%)
• Figure 22. Disposable - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 23. Reusable - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 24. Europe Needle Free Injection Systems Market, by Site of Delivery 2022 & 2028 (%)
• Figure 25. Subcutaneous Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 26. Intramuscular Injector - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 27. Intradermal Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 28. Europe Needle Free Injection Systems Market, by Application 2022 & 2028 (%)
• Figure 29. Vaccine Delivery - Market Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 30. Insulin Delivery - Market Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 31. Pain Management - Market Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 32. Oncology - Market Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 33. Dermatology - Market Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 34. Others - Market Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 35. Europe Needle Free Injection Systems Market, by End User 2022 & 2028 (%)
• Figure 36. Pharmaceutical and Biotechnology Companies - Market Revenue and Forecasts To 2028 (US$ Thousand)
• Figure 37. Hospitals - Market Revenue and Forecasts To 2028 (US$ Thousand)
• Figure 38. Research Laboratories - Market Revenue and Forecasts To 2028 (US$ Thousand)
• Figure 39. Home Care Settings - Market Revenue and Forecasts To 2028 (US$ Thousand)
• Figure 40. Other End User - Market Revenue and Forecasts To 2028 (US$ Thousand)
• Figure 41. Europe: Needle Free Injection System Market, by Key Country - Revenue (2022) (US$ Thousand)
• Figure 42. Europe: Needle Free Injection System Market, by Country, 2022 & 2028 (%)
• Figure 43. Germany: Needle Free Injection System Market - Revenue and Forecast to 2028 (US$ Thousand)
• Figure 44. France: Needle Free Injection System Market - Revenue and Forecast to 2028 (US$ Thousand)
• Figure 45. UK: Needle Free Injection System Market - Revenue and Forecast to 2028 (US$ Thousand)
• Figure 46. Italy: Needle Free Injection System Market - Revenue and Forecast to 2028 (US$ Thousand)
• Figure 47. Spain: Needle Free Injection System Market - Revenue and Forecast to 2028 (US$ Thousand)
• Figure 48. Rest of Europe: Needle Free Injection System Market - Revenue and Forecast to 2028 (US$ Thousand)
• Figure 49. Growth Strategies Done by the Companies in the Market (%)

The Europe needle-free injection systems market is expected to grow from US$ 43.78 million in 2022 to US$ 114.76 million by 2028; it is estimated to grow at a CAGR of 17.4% from 2022 to 2028.

Rising Demand for Vaccines and Biosimilars to Fuel Europe Needle-Free Injection Systems Market

The use of biosimilars is increasing in the treatment of various ailments such as cancer, hepatitis, diabetes, and several other acute and chronic diseases. With the rising prevalence of these illnesses, the need for biosimilars is also increasing, which is presenting a huge opportunity for pharmaceutical & MedTech manufacturers to develop innovative delivery solutions for biosimilars. As several biosimilars and vaccines are administered through injections, the use of needle-free injection technology can provide an easy-to-use and safe method for administering biosimilars without a traditional injection apparatus or skilled staff. Further, many biopharmaceutical manufacturers, vaccine companies, and needle-free device manufacturers are entering into strategic acquisitions and collaborations to leverage the growth potential in the vaccine market. Therefore, the launch of effective and safe drug delivery devices using needle-free injection technology may boost the market growth in the coming years. For instance, in January 2019, Enesi Pharma and Geovax collaborated on multiple vaccines administered using Implavax needle-free injection devices. Also, in August 2021, PharmaJet partnered with Zydus Cadila for the world's first plasmid DNA COVID-19 vaccine delivery via needle-free injection. In addition, the company also partnered with Abnova to produce and supply the COVID-19 mRNA vaccine using needle-free injection technology. Many patients have a phobia for needles, which has led to the low demand for injectable devices; as a result, many companies are now aiming to develop needle-free injectors with effective and painless solutions. Thus, all these factors encouraging the ease-to-use benefit of these injectors will provide more opportunities for the companies to develop innovative products, which is expected to boost the growth of the Europe needle-free injection systems market during the forecast period.

Europe Needle-Free Injection Systems Market Overview

The Europe needle-free injection systems market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Countries such as France and Germany are expected to be the most significant contributors to the needle-free injection system market due to needlestick injuries and diabetes in the region. International Diabetes Federation (IDF) estimated that diabetes prevalence (9.2%) and the number of people with diabetes (61 million) in Europe will increase by 13% by 2045. Sharps injuries, particularly needlestick injuries, increase the risk of potentially life-threatening infections. Every year in Europe, approximately 1.2 million needlestick injuries are suffered by healthcare staff. More than 30 dangerous blood-borne pathogens are transmitted by contaminated needles, including hepatitis B, hepatitis C, and HIV.

Further, Germany is one of the key economies of the European region in terms of revenue generation and future opportunities for the needle-free injection system market. The increasing need for self-administration of drugs in the case of diseases such as diabetes has enhanced the size of the needle-free drug delivery devices industry in Germany. Further, as the prevalence of asthma and other diseases increases across Germany, the demand for inhalers is also expected to rise, which, in turn, drives the needle-free injection system market growth.

Europe Needle-Free Injection Systems Market Revenue and Forecast to 2028 (US$ Million)

Europe Needle-Free Injection Systems Market Segmentation

The Europe needle-free injection systems market is segmented on the basis of product, technology, type, durability, and country. Based on product, the Europe needle-free injection systems market is bifurcated into fillable needle-free injectors and prefilled needle-free injectors. The fillable needle-free injectors segment held a larger share of the market in 2022.

Based on technology, the Europe needle-free injection systems market is segmented into jet-based needle-free injectors, spring-based needle-free injectors, microarray patch injectors, and others. The jet-based needle-free injectors segment registered the largest share of the market in 2022.

Based on type, the Europe needle-free injection systems market is segmented into liquid-based needle-free injectors, projectile-based needle-free injectors, and powder-based needle-free injectors. The liquid-based needle-free injectors segment registered the largest share of the market in 2022.

Based on durability, the Europe needle-free injection systems market is bifurcated into disposable and reusable. The reusable segment held a larger share of the market in 2022.

Based on site of delivery, the Europe needle-free injection systems market is segmented into subcutaneous injectors, intramuscular injectors, and intradermal injectors. The subcutaneous injectors segment held the largest share of the market in 2022.

Based on application, the Europe needle-free injection systems market is segmented into vaccine delivery, insulin delivery, oncology, pain management, dermatology, and others. The vaccine delivery segment held the largest share of the market in 2022.

Based on end user, the Europe needle-free injection systems market is segmented into hospitals, home care settings, research laboratories, pharmaceutical and biotechnology companies, and others. The hospitals segment held the largest share of the market in 2022.

Based on country, the Europe needle-free injection systems market is segmented into Germany, France, Italy, Spain, the UK, and the Rest of Europe. Germany dominated the market in 2022.

Aijex Pharma International Inc., Crossject, Ferring B.V., Medical International Technologies (MIT Canada) Inc., NuGen Medical Devices, and Zealand Pharma A/S are the leading companies operating in the Europe needle-free injection systems market.

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe needle-free injection systems market
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the Europe needle-free injection systems market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the needle-free injection systems market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Table Of Contents

1. Introduction

• 1.1 Study Scope
• 1.2 The Insight Partners Research Report Guidance
• 1.3 Market Segmentation
  • 1.3.1 Europe Needle Free Injection Systems Market - By Product
  • 1.3.2 Europe Needle Free Injection Systems Market - By Technology
  • 1.3.3 Europe Needle Free Injection Systems Market - By Type
  • 1.3.4 Europe Needle Free Injection Systems Market - By Usability
  • 1.3.5 Europe Needle Free Injection Systems Market - By Site of Delivery
  • 1.3.6 Europe Needle Free Injection Systems Market - By Application
  • 1.3.7 Europe Needle Free Injection Systems Market - By End User
  • 1.3.8 Europe Needle Free Injection Systems Market - By Country

2. Europe Needle Free Injection Systems Market- Key Takeaways

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Europe Needle Free Injection Systems Market - Market Landscape

• 4.1 Overview
• 4.2 Europe PEST Analysis
• 4.3 Expert Opinion

5. Europe Needle Free Injection Systems Market - Key Market Dynamics

• 5.1 Market Drivers
  • 5.1.1 Increasing Incidence of Communicable Diseases Due to Needlestick Injuries
  • 5.1.2 Advantages of Using Self-injection Devices
• 5.2 Market Restraints
  • 5.2.1 Higher Development Costs of Needle Free Injectors Compared to Conventional Injection Systems
• 5.3 Market Opportunities
  • 5.3.1 Rising Demand for Vaccines and Biosimilars
• 5.4 Future Trends
  • 5.4.1 Surge in New Technologies for Needle Free Injection System
• 5.5 Impact Analysis

6. Needle Free Injection System Market - Europe Analysis

• 6.1 Europe Needle Free Injection System Marker Revenue Forecast and Analysis

7. Needle Free Injection Systems Market Analysis and Forecasts To 2028 - By Product

• 7.1 Overview
• 7.2 Europe Needle Free Injection Systems Market, By Product 2022 & 2028 (%)
• 7.3 Fillable Needle Free Injectors
  • 7.3.1 Overview
  • 7.3.2 Fillable Needle Free Injectors: Revenue and Forecast to 2028 (US$ Thousand)
• 7.4 Prefilled Needle Free Injectors
  • 7.4.1 Overview
  • 7.4.2 Prefilled Needle Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)

8. Needle Free Injection Systems Market Analysis and Forecasts To 2028 - By Technology

• 8.1 Overview
• 8.2 Europe Needle Free Injection Systems Market, By Technology 2022 & 2028 (%)
• 8.3 Jet-Based Needle-Free Injectors
  • 8.3.1 Overview
  • 8.3.2 Jet-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
• 8.4 Spring-Based Needle-Free Injectors
  • 8.4.1 Overview
  • 8.4.2 Spring-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
• 8.5 Microarray Patch Injectors
  • 8.5.1 Overview
  • 8.5.2 Microarray Patch Injectors - Revenue and Forecast to 2028 (US$ Thousand)
• 8.6 Others
  • 8.6.1 Overview
  • 8.6.2 Others - Revenue and Forecast to 2028 (US$ Thousand)

9. Needle Free Injection Systems Market Analysis and Forecasts To 2028 - By Type

• 9.1 Overview
• 9.2 Europe Needle Free Injection Systems Market, By Type 2022 & 2028 (%)
• 9.3 Liquid-Based Needle-Free Injectors
  • 9.3.1 Overview
  • 9.3.2 Liquid-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
• 9.4 Projectile-Based Needle-Free Injectors
  • 9.4.1 Overview
  • 9.4.2 Projectile-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
• 9.5 Powder-Based Needle-Free Injectors
  • 9.5.1 Overview
  • 9.5.2 Powder-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)

10. Europe Needle Free Injection Systems Market Analysis and Forecasts To 2028 - By Usability

• 10.1 Overview
• 10.2 Europe Needle Free Injection Systems Market, By Usability 2022 & 2028 (%)
• 10.3 Disposable
  • 10.3.1 Overview
  • 10.3.2 Disposable - Revenue and Forecast to 2028 (US$ Thousand)
• 10.4 Reusable
  • 10.4.1 Overview
  • 10.4.2 Reusable - Revenue and Forecast to 2028 (US$ Thousand)

11. Europe Needle Free Injection Systems Market Analysis and Forecasts To 2028 - By Site of Delivery

• 11.1 Overview
• 11.2 Europe Needle Free Injection Systems Market, By Site of Delivery 2022 & 2028 (%)
• 11.3 Subcutaneous Injectors
  • 11.3.1 Overview
  • 11.3.2 Subcutaneous Injectors - Revenue and Forecast to 2028 (US$ Thousand)
• 11.4 Intramuscular Injectors
  • 11.4.1 Overview
  • 11.4.2 Intramuscular Injectors - Revenue and Forecast to 2028 (US$ Thousand)
• 11.5 Intradermal Injectors
  • 11.5.1 Overview
  • 11.5.2 Intradermal Injectors - Revenue and Forecast to 2028 (US$ Thousand)

12. Europe Needle Free Injection Systems Market Analysis and Forecasts To 2028 - By Application

• 12.1 Overview
• 12.2 Europe Needle Free Injection Systems Market, By Application 2022 & 2028 (%)
• 12.3 Vaccine Delivery
  • 12.3.1 Overview
  • 12.3.2 Vaccine Delivery - Market Revenue and Forecast to 2028 (US$ Thousand)
• 12.4 Insulin Delivery
  • 12.4.1 Overview
  • 12.4.2 Insulin Delivery - Market Revenue and Forecast to 2028 (US$ Thousand)
• 12.5 Pain Management
  • 12.5.1 Overview
  • 12.5.2 Pain Management - Market Revenue and Forecast to 2028 (US$ Thousand)
• 12.6 Oncology
  • 12.6.1 Overview
  • 12.6.2 Oncology - Market Revenue and Forecast to 2028 (US$ Thousand)
• 12.7 Dermatology
  • 12.7.1 Overview
  • 12.7.2 Dermatology - Market Revenue and Forecast to 2028 (US$ Thousand)
• 12.8 Others
  • 12.8.1 Overview
  • 12.8.2 Others - Market Revenue and Forecast to 2028 (US$ Thousand)

13. Europe Needle Free Injection Systems Market Analysis- By End User

• 13.1 Overview
• 13.2 Europe Needle Free Injection Systems Market, By End User 2022 & 2028 (%)
• 13.3 Pharmaceutical and Biotechnology Companies
  • 13.3.1 Overview
  • 13.3.2 Pharmaceutical and Biotechnology Companies - Market Revenue and Forecasts To 2028 (US$ Thousand)
• 13.4 Hospitals
  • 13.4.1 Overview
  • 13.4.2 Hospitals - Market Revenue and Forecasts To 2028 (US$ Thousand)
• 13.5 Research Laboratories
  • 13.5.1 Overview
  • 13.5.2 Research Laboratories - Market Revenue and Forecasts To 2028 (US$ Thousand)
• 13.6 Home Care Settings
  • 13.6.1 Overview
  • 13.6.2 Home Care Settings - Market Revenue and Forecasts To 2028 (US$ Thousand)
• 13.7 Other End User
  • 13.7.1 Overview
  • 13.7.2 Other End User - Market Revenue and Forecasts To 2028 (US$ Thousand)

14. Europe Needle Free Injection Systems Market Revenue and Forecasts to 2028 - Country Analysis

• 14.1 Overview
  • 14.1.1 Europe: Needle Free Injection System Market, by Country, 2022 & 2028 (%)
    • 14.1.1.1 Germany: Needle Free Injection System Market - Revenue and Forecast to 2028 (US$ Thousand)
      • 14.1.1.1.1 Germany: Needle Free Injection System Market - Revenue and Forecast to 2028 (US$ Thousand)
      • 14.1.1.1.2 Germany: Needle Free Injection System Market, by Product, 2019-2028 (US$ Thousand)
      • 14.1.1.1.3 Germany: Needle Free Injection System Market, by Technology, 2019-2028 (US$ Thousand)
      • 14.1.1.1.4 Germany: Needle Free Injection System Market, by Type, 2019-2028 (US$ Thousand)
      • 14.1.1.1.5 Germany: Needle Free Injection System Market, by Usability, 2019-2028 (US$ Thousand)
      • 14.1.1.1.6 Germany: Needle Free Injection System Market, by Site of Delivery, 2019-2028 (US$ Thousand)
      • 14.1.1.1.7 Germany: Needle Free Injection System Market, by Application, 2019-2028 (US$ Thousand)
      • 14.1.1.1.8 Germany: Needle Free Injection System Market, by End User, 2019-2028 (US$ Thousand)
    • 14.1.1.2 France: Needle Free Injection System Market - Revenue and Forecast to 2028 (US$ Thousand)
      • 14.1.1.2.1 France: Needle Free Injection System Market - Revenue and Forecast to 2028 (US$ Thousand)
      • 14.1.1.2.2 France: Needle Free Injection System Market, by Product, 2019-2028 (US$ Thousand)
      • 14.1.1.2.3 France: Needle Free Injection System Market, by Technology, 2019-2028 (US$ Thousand)
      • 14.1.1.2.4 France: Needle Free Injection System Market, by Type, 2019-2028 (US$ Thousand)
      • 14.1.1.2.5 France: Needle Free Injection System Market, by Usability, 2019-2028 (US$ Thousand)
      • 14.1.1.2.6 France: Needle Free Injection System Market, by Site of Delivery, 2019-2028 (US$ Thousand)
      • 14.1.1.2.7 France: Needle Free Injection System Market, by Application, 2019-2028 (US$ Thousand)
      • 14.1.1.2.8 France: Needle Free Injection System Market, by End User, 2019-2028 (US$ Thousand)
    • 14.1.1.3 UK: Needle Free Injection System Market - Revenue and Forecast to 2028 (US$ Thousand)
      • 14.1.1.3.1 UK: Needle Free Injection System Market - Revenue and Forecast to 2028 (US$ Thousand)
      • 14.1.1.3.2 UK: Needle Free Injection System Market, by Product, 2019-2028 (US$ Thousand)
      • 14.1.1.3.3 UK: Needle Free Injection System Market, by Technology, 2019-2028 (US$ Thousand)
      • 14.1.1.3.4 UK: Needle Free Injection System Market, by Type, 2019-2028 (US$ Thousand)
      • 14.1.1.3.5 UK: Needle Free Injection System Market, by Usability, 2019-2028 (US$ Thousand)
      • 14.1.1.3.6 UK: Needle Free Injection System Market, by Site of Delivery, 2019-2028 (US$ Thousand)
      • 14.1.1.3.7 UK: Needle Free Injection System Market, by Application, 2019-2028 (US$ Thousand)
      • 14.1.1.3.8 UK: Needle Free Injection System Market, by End User, 2019-2028 (US$ Thousand)
    • 14.1.1.4 Italy: Needle Free Injection System Market - Revenue and Forecast to 2028 (US$ Thousand)
      • 14.1.1.4.1 Italy: Needle Free Injection System Market - Revenue and Forecast to 2028 (US$ Thousand)
      • 14.1.1.4.2 Italy: Needle Free Injection System Market, by Product, 2019-2028 (US$ Thousand)
      • 14.1.1.4.3 Italy: Needle Free Injection System Market, by Technology, 2019-2028 (US$ Thousand)
      • 14.1.1.4.4 Italy: Needle Free Injection System Market, by Type, 2019-2028 (US$ Thousand)
      • 14.1.1.4.5 Italy: Needle Free Injection System Market, by Usability, 2019-2028 (US$ Thousand)
      • 14.1.1.4.6 Italy: Needle Free Injection System Market, by Site of Delivery, 2019-2028 (US$ Thousand)
      • 14.1.1.4.7 Italy: Needle Free Injection System Market, by Application, 2019-2028 (US$ Thousand)
      • 14.1.1.4.8 Italy: Needle Free Injection System Market, by End User, 2019-2028 (US$ Thousand)
    • 14.1.1.5 Spain: Needle Free Injection System Market - Revenue and Forecast to 2028 (US$ Thousand)
      • 14.1.1.5.1 Overview
      • 14.1.1.5.2 Spain: Needle Free Injection System Market - Revenue and Forecast to 2028 (US$ Thousand)
      • 14.1.1.5.3 Spain: Needle Free Injection System Market, by Product- 2019-2028 (US$ Thousand)
      • 14.1.1.5.4 Spain: Needle Free Injection System Market, by Technology, 2019-2028 (US$ Thousand)
      • 14.1.1.5.5 Spain: Needle Free Injection System Market, by Type, 2019-2028 (US$ Thousand)
      • 14.1.1.5.6 Spain: Needle Free Injection System Market, by Usability, 2019-2028 (US$ Thousand)
      • 14.1.1.5.7 Spain: Needle Free Injection System Market, by Site of Delivery, 2019-2028 (US$ Thousand)
      • 14.1.1.5.8 Spain: Needle Free Injection System Market, by Application- 2019-2028 (US$ Thousand)
      • 14.1.1.5.9 Spain: Needle Free Injection System Market, by End User, 2019-2028 (US$ Thousand)
    • 14.1.1.6 Rest of Europe: Needle Free Injection System Market - Revenue and Forecast to 2028 (US$ Thousand)
      • 14.1.1.6.1 Overview
      • 14.1.1.6.2 Rest of Europe: Needle Free Injection System Market - Revenue and Forecast to 2028 (US$ Thousand)
      • 14.1.1.6.3 Rest of Europe: Needle Free Injection System Market, by Product- 2019-2028 (US$ Thousand)
      • 14.1.1.6.4 Rest of Europe: Needle Free Injection System Market, by Technology, 2019-2028 (US$ Thousand)
      • 14.1.1.6.5 Rest of Europe: Needle Free Injection System Market, by Type, 2019-2028 (US$ Thousand)
      • 14.1.1.6.6 Rest of Europe: Needle Free Injection System Market, by Usability, 2019-2028 (US$ Thousand)
      • 14.1.1.6.7 Rest of Europe: Needle Free Injection System Market, by Site of Delivery, 2019-2028 (US$ Thousand)
      • 14.1.1.6.8 Rest of Europe: Needle Free Injection System Market, by Application- 2019-2028 (US$ Thousand)
      • 14.1.1.6.9 Rest of Europe: Needle Free Injection System Market, by End User, 2019-2028 (US$ Thousand)

15. Needle-Free Injection System Market-Industry Landscape

• 15.1 Overview
• 15.2 Growth Strategies Done by the Companies in the Market (%)
• 15.3 Organic Developments
  • 15.3.1 Overview
• 15.4 Inorganic Developments
  • 15.4.1 Overview

16. Company Profiles

• 16.1 Crossject
  • 16.1.1 Key Facts
  • 16.1.2 Business Description
  • 16.1.3 Products and Services
  • 16.1.4 Financial Overview
  • 16.1.5 SWOT Analysis
  • 16.1.6 Key Developments
• 16.2 Zealand Pharma A/S
  • 16.2.1 Key Facts
  • 16.2.2 Business Description
  • 16.2.3 Products and Services
  • 16.2.4 Financial Overview
  • 16.2.5 SWOT Analysis
  • 16.2.6 Key Developments
• 16.3 Medical International Technologies (MIT Canada) Inc.
  • 16.3.1 Key Facts
  • 16.3.2 Business Description
  • 16.3.3 Products and Services
  • 16.3.4 Financial Overview
  • 16.3.5 SWOT Analysis
  • 16.3.6 Key Developments
• 16.4 NuGen Medical Devices
  • 16.4.1 Key Facts
  • 16.4.2 Business Description
  • 16.4.3 Products and Services
  • 16.4.4 Financial Overview
  • 16.4.5 SWOT Analysis
  • 16.4.6 Key Developments
• 16.5 Ferring B.V.
  • 16.5.1 Key Facts
  • 16.5.2 Business Description
  • 16.5.3 Products and Services
  • 16.5.4 Financial Overview
  • 16.5.5 SWOT Analysis
  • 16.5.6 Key Developments
• 16.6 Aijex Pharma International Inc.
  • 16.6.1 Key Facts
  • 16.6.2 Business Description
  • 16.6.3 Products and Services
  • 16.6.4 Financial Overview
  • 16.6.5 SWOT Analysis
  • 16.6.6 Key Developments

17. Appendix

• 17.1 About The Insight Partners
• 17.2 Glossary of Terms